News >

Expert Highlights Breakthroughs and Next Steps in RCC Paradigm

Brittany Cote
Published: Thursday, Apr 02, 2020

Matthew T. Campbell, MD, MS, assistant professor in the Department of Genitourinary Medical Oncology of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center

Matthew T. Campbell, MD, MS

Single-agent immunotherapy and combination regimens have revolutionized the treatment paradigm for patients with renal cell carcinoma (RCC), explained Matthew T. Campbell, MD, MS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication